A team of engineers, scientists and doctors have developed a device that provides those who are struggling to breathe because of moderate to severe Covid symptoms with a form of oxygen therapy.
This provision of oxygen is also known as continuous positive airway pressure (CPAP). The device was found to be well tolerated by users and able to help the flow of oxygen without inducing hypoxia (low oxygen levels) or hypercapnia (carbon dioxide build-up in the bloodstream).
The breathing aid was developed with low costs in mind, an ideal solution for meeting clinical demands in poorer-resource health settings afflicted by the pandemic.
... to continue reading you must be subscribed
